abstract |
A fusion protein comprising MAP3K3 (mitogen activated protein kinase kinase3) relates to a cancer diagnostic marker and / or therapeutic target, comprising a fusion protein comprising MAP3K3, a cancer comprising a molecule that specifically binds to the fusion protein A diagnostic composition, a method for providing information for cancer diagnosis using the same, a composition for preventing and / or treating cancer comprising an inhibitor of the fusion protein, and a method for screening a cancer drug using the fusion protein are provided. |